Journal Article Corrected proof Chances/Challenges of the Role of New Beta-lactamase Inhibitors Against the Growing Threat of NDM-producing Escherichia coli With Penicillin-binding Protein 3 Mutations Get access Claudia Fabrizio, Claudia Fabrizio Infectious and Tropical Diseases Clinic, S. Giuseppe Moscati Hospital, Taranto, Italy Correspondence: C. Fabrizio, Infectious and Tropical Diseases Clinic, S. Giuseppe Moscati Hospital, via per Martina Franca, 74010, Taranto, Italy (claudia.fabrizio@asl.taranto.it). https://orcid.org/0000-0002-9057-490X Search for other works by this author on: Oxford Academic PubMed Google Scholar Carlo Tascini Carlo Tascini Infectious Diseases Clinic, Department of Medicine (DMED), University of Udine, Udine, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciae343, https://doi.org/10.1093/cid/ciae343 Published: 23 August 2024 Article history Corrected and typeset: 23 August 2024 Published: 23 August 2024
No takes yet. Share an insight, caveat, or question.
Fabrizio et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: